Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity. Possible causes of hypertriglyceridemia and reduced body mass with VLDL receptor deficiency.
about
Low-density lipoprotein receptor (LDLR) family orchestrates cholesterol homeostasisLipids and the endothelium: bidirectional interactionsA common VLDLR polymorphism interacts with APOE genotype in the prediction of carotid artery disease riskAdipocyte LDL receptor-related protein-1 expression modulates postprandial lipid transport and glucose homeostasis in mice.Gene network and pathway analysis of bovine mammary tissue challenged with Streptococcus uberis reveals induction of cell proliferation and inhibition of PPARgamma signaling as potential mechanism for the negative relationships between immune responPeroxisome proliferator-activated receptor-gamma regulates the expression and function of very-low-density lipoprotein receptor.Defective lipid delivery modulates glucose tolerance and metabolic response to diet in apolipoprotein E-deficient miceA novel adaptive method for the analysis of next-generation sequencing data to detect complex trait associations with rare variants due to gene main effects and interactions.Triglyceride Rich Lipoprotein -LPL-VLDL Receptor and Lp(a)-VLDL Receptor Pathways for Macrophage Foam Cell Formation.Adipose tissue pathways involved in weight loss of cancer cachexiamTOR Inhibition Subdues Milk Disorder Caused by Maternal VLDLR LossLipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy.Variations of very low-density lipoprotein receptor subtype expression in gastrointestinal adenocarcinoma cells with various differentiations.Triglycerides and heart disease: still a hypothesis?Apolipoprotein E4 exaggerates diabetic dyslipidemia and atherosclerosis in mice lacking the LDL receptor.The VLDL receptor promotes lipotoxicity and increases mortality in mice following an acute myocardial infarction.Translational analysis of mouse and human placental protein and mRNA reveals distinct molecular pathologies in human preeclampsia.Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis.Dietary cholesterol effects on adipose tissue inflammation.Macrophage VLDL receptor promotes PAFAH secretion in mother's milk and suppresses systemic inflammation in nursing neonates.Lipoprotein receptors--an evolutionarily ancient multifunctional receptor family.Apolipoprotein E induces antiinflammatory phenotype in macrophagesAdiponectin reduces plasma triglyceride by increasing VLDL triglyceride catabolism.Peroxisome proliferator-activated receptor gamma agonist rosiglitazone increases expression of very low density lipoprotein receptor gene in adipocytesVery low density lipoprotein receptor (VLDLR) expression is a determinant factor in adipose tissue inflammation and adipocyte-macrophage interaction.Nuclear factor (erythroid-derived 2)-like 2 activation-induced hepatic very-low-density lipoprotein receptor overexpression in response to oxidative stress contributes to alcoholic liver disease in mice.Clusterin signals via ApoER2/VLDLR and induces meiosis of male germ cells.Very-low-density lipoprotein: complex particles in cardiac energy metabolism.Acylation-stimulating protein (ASP) deficiency induces obesity resistance and increased energy expenditure in ob/ob mice.Upregulation of hepatic VLDLR via PPARα is required for the triglyceride-lowering effect of fenofibrateCardiac lipoprotein lipase activity in the hypertrophied heart may be regulated by fatty acid flux.Apolipoprotein B production reduces lipotoxic cardiomyopathy: studies in heart-specific lipoprotein lipase transgenic mouse.Cardiac-specific knock-out of lipoprotein lipase alters plasma lipoprotein triglyceride metabolism and cardiac gene expression.Utilization of triacylglycerol-rich lipoproteins by the working rat heart: routes of uptake and metabolic fates.Beneficial effect of 3,4,5,6-tetrahydroxyxanthone on dyslipidemia in apolipoprotein E-deficient mice.The VLDL receptor plays a major role in chylomicron metabolism by enhancing LPL-mediated triglyceride hydrolysis.Increased adiposity in DNA binding-dependent androgen receptor knockout male mice associated with decreased voluntary activity and not insulin resistance.Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease.Undaria pinnatifida soluble fiber regulates Angptl3-LPL pathway to lessen hyperlipidemia in mice.A Localized Negative Genetic Correlation Constrains Microevolution of Coat Color in Wild Sheep
P2860
Q24608930-BE22FD68-A2F9-4952-ABC6-E370EDC78B21Q26860086-46EAB8AB-91AF-4882-8462-45B8ABA09D2DQ28259831-EAFE4F4B-0FBB-471C-8A44-7DB312B73160Q30480233-FC4D940F-12D8-40BF-931B-91396982CA3EQ30898776-4FA3CC7D-84DA-47A6-A61F-71A63A546865Q33589043-C9490A0B-74F2-4914-A9B8-C0C7E0921614Q33697550-29110609-BFAB-4A4B-A663-45BF6A58C132Q33728642-CEC4B5A7-5AE9-4B27-BE4B-44805972D81AQ33752256-13FAF6C1-0702-4990-AEC5-5D429305001CQ33847854-27A90EB6-E874-4649-80D8-919249C24219Q33926184-09246FED-D8C5-4E82-A2BB-53BB858D05BDQ34829428-E0A84144-C2C3-47AB-92CA-0CEAD6661984Q35011299-BD441B6D-FDC6-4AC2-8E89-877F61A38FE1Q35120360-B68A6254-B4A0-4C94-B7CE-C9703DE1FDFAQ35179999-5A00E031-33BA-472A-8F4A-2B8F26BE47A0Q35572373-2573BD0D-891F-41C0-BC1F-CCD5BD5C0704Q35610680-61E0A308-8A68-4A59-806E-482E59F8E859Q35987553-722B6D67-2850-410C-953F-43418EAD6AB4Q36436923-5E2A469A-5AAB-4C07-BFE3-5A8CB49900A1Q36462361-29EB6043-8141-44D8-BF44-B63751ED3710Q36486210-43A9F5CF-3E1D-42AB-A36B-FC0725A58862Q36486217-CAE7A9A0-7AF7-482C-9DC3-8C97A0805A4BQ36756510-D25720D2-A4D1-42D8-B962-288A6AC31EFEQ37431634-04E75105-93A4-4117-8AF4-27E1D514E238Q37488539-0B2550AE-3394-43EB-80B7-D4E20166BFF6Q37666136-4908FEBA-65BE-412F-9ABB-0C4542A63F27Q37733021-A78211A5-7AC9-446C-8C2C-739898D0D3EDQ37902919-D30ED9B3-ADF5-4065-AB60-77188620B268Q38362744-B6817B3C-44CB-43C8-9E3A-618F2ABFCDE6Q41819084-16960823-B859-4D2C-B05F-301C07A5A077Q42659033-DE4AEA80-1795-4C75-907D-1EFF1F52FE50Q44666420-94F4D1A3-441A-416E-A351-A10174505C79Q44804024-076A14D1-929F-439E-B401-5311F2376F55Q44879637-78B31422-5300-494E-9825-DFF47583E4A8Q46194799-C10A46E2-78F1-4C92-A8BA-E5D1478D7FA3Q47598134-6978FFB9-466D-4E61-ACC1-94FD716F5C53Q48126981-EDA0A74D-B310-4F81-941F-507D90BA8A4FQ49385649-65F0DDFD-86A7-4C3D-A01C-B1C0904DF86AQ51062955-6AA8E9E5-3D88-40FD-B301-832B481E475CQ57242466-DB0A28CF-E0E2-4747-9B18-7E8210CAD86C
P2860
Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity. Possible causes of hypertriglyceridemia and reduced body mass with VLDL receptor deficiency.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Very low density lipoprotein ( ...... with VLDL receptor deficiency.
@en
type
label
Very low density lipoprotein ( ...... with VLDL receptor deficiency.
@en
prefLabel
Very low density lipoprotein ( ...... with VLDL receptor deficiency.
@en
P2093
P356
P1476
Very low density lipoprotein ( ...... with VLDL receptor deficiency.
@en
P2093
Andre Bensadoun
E Peer Lutz
Hiroaki Yagyu
Ira J Goldberg
Steven Marks
Sungshin Y Choi
Yunying Hu
P304
10037-10043
P356
10.1074/JBC.M109966200
P407
P577
2002-01-14T00:00:00Z